|
|
||||||||
Ann Thorac Surg 2000;70:157-161
© 2000 The Society of Thoracic Surgeons
a Divisions of Cardiology and Cardiovascular Surgery, Shin Kong Wu Ho-Su Memorial Hospital, Taipei, Taiwan
b National Yang-Ming University, Taipei, Taiwan
Address reprint requests to Dr Shih-Huang Lee, Division of Cardiology, Shin Kong Wu Ho-Su Memorial Hospital, 95 Wen Chang Rd, Shih Lin, Taipei, Taiwan
e-mail: ufae0061{at}ms7.hinet.net
Background. Atrial fibrillation occurs in 10% to 40% of patients who undergo coronary artery bypass grafting. This prospective study assesses the safety and efficacy of low-dose intravenous amiodarone in the prevention of atrial fibrillation after coronary artery bypass grafting.
Methods. One hundred forty patients were randomly divided into two groups: an amiodarone group (n = 74) receiving intravenous amiadarone in a loading dose of 150 mg and maintenance dose of 0.4 mg · kg-1 · h-1 for 3 days before and 5 days after operation and a control group (n = 76) receiving matching infusions of 5% glucose solution.
Results. Atrial fibrillation occurred in 9 (12%) of the amiodarone group patients and in 26 (34%) of the control group patients during hospitalization (p < 0.01). The maximum ventricular rate during atrial fibrillation was significantly slower in the amiodarone group (107 ± 21) than in the control group (138 ±24 beats per minute, p < 0.01). The duration of atrial fibrillation in the amiodarone group (1.1 ± 1.2 hours) was significantly shorter than that in the control group (3.2 ± 1.3 hours, p = 0.01). The two groups had no significant differences in incidence of major morbidity (8 of 74 versus 8 of 76 in amiodarone and control groups, respectively) or mortality (4 of 74 versus 5 of 76). However, the control group had significantly longer intensive care unit stays (132 ± 24 versus 111 ± 19 hours, p < 0.01).
Conclusions. Perioperative low-dose intravenous amiodarone significantly reduces the incidence, ventricular rate, and duration of atrial fibrillation after coronary artery bypass grafting. Furthermore, low-dose intravenous amiodarone is well tolerated and does not increase the risk of intraoperative or postoperative complications.
This article has been cited by other articles:
![]() |
J. H. Levy, K. A. Tanaka, and J. M. Bailey Cardiac Surgical Pharmacology Card. Surg. Adult, January 1, 2008; 3(2008): 77 - 110. [Full Text] |
||||
![]() |
D. C. Burgess, M. J. Kilborn, and A. C. Keech Interventions for prevention of post-operative atrial fibrillation and its complications after cardiac surgery: a meta-analysis Eur. Heart J., December 1, 2006; 27(23): 2846 - 2857. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. M. Bagshaw, P. D. Galbraith, L. B. Mitchell, R. Sauve, D. V. Exner, and W. A. Ghali Prophylactic Amiodarone for Prevention of Atrial Fibrillation After Cardiac Surgery: A Meta-Analysis Ann. Thorac. Surg., November 1, 2006; 82(5): 1927 - 1937. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. J. Barnes, E. A. Kirkland, P. A. Howard, D. W. Grauer, M. E. Gorton, J. B. Kramer, G. F. Muehlebach, and W. A. Reed Risk-stratified evaluation of amiodarone to prevent atrial fibrillation after cardiac surgery. Ann. Thorac. Surg., October 1, 2006; 82(4): 1332 - 1337. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Halonen, T. Hakala, T. Auvinen, J. Karjalainen, A. Turpeinen, A. Uusaro, P. Halonen, J. Hartikainen, and M. Hippelainen Intravenous Administration of Metoprolol Is More Effective Than Oral Administration in the Prevention of Atrial Fibrillation After Cardiac Surgery Circulation, July 4, 2006; 114(1_suppl): I-1 - I-4. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Budeus, M. Hennersdorf, S. Perings, S. Rohlen, S. Schnitzler, O. Felix, K. Reimert, P. Feindt, E. Gams, N. Lehmann, et al. Amiodarone prophylaxis for atrial fibrillation of high-risk patients after coronary bypass grafting: a prospective, double-blinded, placebo-controlled, randomized study Eur. Heart J., July 1, 2006; 27(13): 1584 - 1591. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. A. Patel, C. M. White, E. L. Gillespie, J. Kluger, and C. I. Coleman Safety of amiodarone in the prevention of postoperative atrial fibrillation: A meta-analysis Am. J. Health Syst. Pharm., May 1, 2006; 63(9): 829 - 837. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Brantman and J. Howie Use of Amiodarone to Prevent Atrial Fibrillation After Cardiac Surgery Crit. Care Nurse, February 1, 2006; 26(1): 48 - 58. [Full Text] [PDF] |
||||
![]() |
L. B. Mitchell, D. V. Exner, D. G. Wyse, C. J. Connolly, G. D. Prystai, A. J. Bayes, W. T. Kidd, T. Kieser, J. J. Burgess, A. Ferland, et al. Prophylactic Oral Amiodarone for the Prevention of Arrhythmias That Begin Early After Revascularization, Valve Replacement, or Repair: PAPABEAR: A Randomized Controlled Trial JAMA, December 28, 2005; 294(24): 3093 - 3100. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. D. Aasbo, A. T. Lawrence, K. Krishnan, M. H. Kim, and R. G. Trohman Amiodarone Prophylaxis Reduces Major Cardiovascular Morbidity and Length of Stay after Cardiac Surgery: A Meta-Analysis Ann Intern Med, September 6, 2005; 143(5): 327 - 336. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. L Gillespie, C. I Coleman, S. Sander, J. Kluger, K. A Gryskiewicz, and C M. White Effect of Prophylactic Amiodarone on Clinical and Economic Outcomes After Cardiothoracic Surgery: A Meta-Analysis Ann. Pharmacother., September 1, 2005; 39(9): 1409 - 1415. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. W. Hogue Jr., L. L. Creswell, D. D. Gutterman, and L. A. Fleisher Epidemiology, Mechanisms, and Risks: American College of Chest Physicians Guidelines for the Prevention and Management of Postoperative Atrial Fibrillation After Cardiac Surgery Chest, August 1, 2005; 128(2_suppl): 9S - 16S. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Bradley, L. L. Creswell, C. W. Hogue Jr., A. E. Epstein, E. N. Prystowsky, and E. G. Daoud Pharmacologic Prophylaxis: American College of Chest Physicians Guidelines for the Prevention and Management of Postoperative Atrial Fibrillation After Cardiac Surgery Chest, August 1, 2005; 128(2_suppl): 39S - 47S. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Kailasam, C. A. Palin, and C. W. Hogue Jr Atrial Fibrillation After Cardiac Surgery: An Evidence-Based Approach to Prevention Seminars in Cardiothoracic and Vascular Anesthesia, March 1, 2005; 9(1): 77 - 85. [Abstract] [PDF] |
||||
![]() |
D. Mikroulis, V. Didilis, F. Konstantinou, K. Tsakiridis, G. Vretzakis, and G. Bougioukas Diltiazem versus Amiodarone to Prevent Atrial Fibrillation in Coronary Surgery Asian Cardiovasc Thorac Ann, March 1, 2005; 13(1): 47 - 52. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. J. DiDomenico and M. G. Massad Pharmacologic Strategies for Prevention of Atrial Fibrillation After Open Heart Surgery Ann. Thorac. Surg., February 1, 2005; 79(2): 728 - 740. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Dunning, P. Botha, and M. Amanullah Prophylactic Amiodarone effectively prevents post-operative atrial fibrillation Interactive CardioVascular and Thoracic Surgery, September 1, 2004; 3(3): 510 - 515. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Engoren Is a Charge a Cost If Nobody Pays It? Chest, September 1, 2004; 126(3): 662 - 664. [Full Text] [PDF] |
||||
![]() |
J. Melo, P. Voigt, B. Sonmez, M. Ferreira, M. Abecasis, M. Rebocho, A. Timoteo, C. Aguiar, S. Tansal, H. Arbatli, et al. Ventral cardiac denervation reduces the incidence of atrial fibrillation after coronary artery bypass grafting J. Thorac. Cardiovasc. Surg., February 1, 2004; 127(2): 511 - 516. [Abstract] [Full Text] [PDF] |
||||
![]() |
W.-K. Au, S.-W. Chiu, M.-P. Sun, L.-C. Cheung, and L.-C. Cheng Biatrial Pacing to Prevent Atrial Fibrillation After Coronary Artery Bypass Asian Cardiovasc Thorac Ann, September 1, 2003; 11(3): 222 - 225. [Abstract] [Full Text] |
||||
![]() |
T. Yagdi, S. Nalbantgil, F. Ayik, A. Apaydin, F. Islamoglu, H. Posacioglu, T. Calkavur, Y. Atay, and S. Buket Amiodarone reduces the incidence of atrial fibrillation after coronary artery bypass grafting J. Thorac. Cardiovasc. Surg., June 1, 2003; 125(6): 1420 - 1425. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Shin, K. Hashizume, Y. Iino, K. Koizumi, T. Matayoshi, and R. Yozu Effects of atrial fibrillation on coronary artery bypass graft flow Eur. J. Cardiothorac. Surg., February 1, 2003; 23(2): 175 - 178. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Bailey, K. A. Tanaka, and J. H. Levy Cardiac Surgical Pharmacology Card. Surg. Adult, January 1, 2003; 2(2003): 85 - 118. [Full Text] |
||||
![]() |
L. Yazicioglu, S. Eryilmaz, M. Sirlak, M. B. Inan, A. Aral, R. Tasoz, and H. Akalin The effect of preoperative digitalis and atenolol combination on postoperative atrial fibrillation incidence Eur. J. Cardiothorac. Surg., September 1, 2002; 22(3): 397 - 401. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Crystal, S. J. Connolly, K. Sleik, T. J. Ginger, and S. Yusuf Interventions on Prevention of Postoperative Atrial Fibrillation in Patients Undergoing Heart Surgery: A Meta-Analysis Circulation, July 2, 2002; 106(1): 75 - 80. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. K. Haan and S. A. Geraci Role of amiodarone in reducing atrial fibrillation after cardiac surgery in adults Ann. Thorac. Surg., May 1, 2002; 73(5): 1665 - 1669. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Tokmakoglu, O. Kandemir, S. Gunaydin, Z. Catav, C. Yorgancioglu, and Y. Zorlutuna Amiodarone versus digoxin and metoprolol combination for the prevention of postcoronary bypass atrial fibrillation Eur. J. Cardiothorac. Surg., March 1, 2002; 21(3): 401 - 405. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |